Exploring the Value of 18F-AlF-FAPI PET/CT in Assessing the Activity of Thyroid Eye Disease

Launched by PEKING UNIVERSITY THIRD HOSPITAL · Apr 7, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at a new imaging test called 18F-AlF-FAPI PET/CT to see how well it can assess the activity of Thyroid Eye Disease (TED). TED is a condition that can cause swelling and discomfort around the eyes. The researchers want to find out if this new test is better than a standard test called 99mTc-DTPA SPECT/CT for diagnosing TED and checking how well treatments are working.

To participate in this study, you need to be at least 18 years old and have been diagnosed with TED. It's important that you fully understand what the study involves and agree to take part by signing a consent form. However, if you have serious liver or kidney problems, find it hard to lie still for about 5 minutes, or have certain other medical conditions, you may not be eligible. If you join the trial, expect to undergo imaging tests that will help the researchers learn more about TED and improve future care for patients with this condition.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Age ≥ 18 years;
• • 2. Patients diagnosed with TED;
• • 3. Complete understanding and voluntary participation in this study, with the signing of an informed consent form.
• Exclusion Criteria:
• • 1. Severe liver or kidney dysfunction;
• • 2. Inability to maintain a supine position for 5 minutes to cooperate with the examination;
• • 3. Suffering from claustrophobia or other psychiatric disorders;
• • 4. Patients planning pregnancy or in the prenatal or lactation period;
• • 5. Other conditions deemed unsuitable for participation in the trial by the investigator.